Anthony S. Gibney - 15 Apr 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
15 Apr 2024
Net transactions value
$0
Form type
4
Filing time
16 Apr 2024, 16:31:28 UTC
Previous filing
13 Jul 2023
Next filing
19 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Award $0 +45,000 $0.000000 45,000 15 Apr 2024 Common Stock 45,000 $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying such option will vest in 36 equal monthly installments on the last day of each month commencing on April 30, 2024, subject to the Reporting Person's continuous service through each vesting date.